Document And Entity Information |
Mar. 03, 2023 |
---|---|
Cover [Abstract] | |
Document Type | 8-K/A |
Amendment Flag | true |
Amendment Description | On March 7, 2023, Corbus Pharmaceuticals Holdings, Inc. (the "Company") filed a Current Report on Form 8-K (the "Original Form 8-K") to report Craig Millian's resignation as Chief Operating Officer. The Company is filing this amendment to the Original Form 8-K to disclose the terms of the Separation and General Release Agreement, by and between Mr. Millian and the Company. No other modifications have been made to the Original Form 8-K. |
Document Period End Date | Mar. 03, 2023 |
Entity Registrant Name | CORBUS PHARMACEUTICALS HOLDINGS, INC. |
Entity Central Index Key | 0001595097 |
Entity Emerging Growth Company | false |
Securities Act File Number | 001-37348 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 46-4348039 |
Entity Address, Address Line One | 500 River Ridge Drive |
Entity Address, City or Town | Norwood |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02062 |
City Area Code | 617 |
Local Phone Number | 963-0100 |
Entity Information, Former Legal or Registered Name | Not Applicable |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $0.0001 per share |
Trading Symbol | CRBP |
Security Exchange Name | NASDAQ |